Jun 07, 2019
Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders
May 08, 2019
Aratana Therapeutics Reports First Quarter 2019 Financial Results
Mar 12, 2019
Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Feb 12, 2019
Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
Oct 22, 2018
Aratana Therapeutics to Report Third Quarter 2018 Financial Results
May 21, 2018
Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital
Mar 13, 2018
Aratana Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 02, 2018
Aratana Therapeutics to Participate at Upcoming Investment Conferences
Dec 20, 2017
Aratana Therapeutics Granted Conditional License for a Canine Osteosarcoma Therapeutic
Dec 15, 2017
Aratana Therapeutics Announces Study Results for AT-016
Nov 28, 2017
Aratana Therapeutics, Inc. Announces Termination of Offering of Common Stock
Nov 27, 2017
Aratana Therapeutics, Inc. Announces Proposed Public Offering
Nov 10, 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe
Oct 30, 2017
Aratana Therapeutics to Present at Credit Suisse Healthcare Conference
Oct 13, 2017
Aratana Therapeutics Announces Launch of ENTYCE® (capromorelin oral solution)
Oct 05, 2017
Aratana Therapeutics to Report Third Quarter 2017 Financial Results
Jul 26, 2017
Aratana Therapeutics Announces Positive Results for AT-003
Jul 18, 2017
Aratana Therapeutics to Report Second Quarter 2017 Financial Results